ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Hodgkin Lymphoma in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Mantle-Cell Lymphoma
Marginal Zone B-Cell Lymphoma

Non-Hodgkin Lymphoma trials near Berlin, BE, DEU:

Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma (BELINDA)

to Standard Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracyc...

Active, not recruiting
Non-Hodgkin Lymphoma
Drug: Platinum-based immunochemotherapy followed in responding patients with high dose chemotherapy and autologous hematopoietic stem cell transplant (HSCT)
Drug: Tisagenlecleucel after optional bridging and lymphodepleting chemotherapy

Phase 3

Novartis
Novartis

Berlin, Germany and 71 other locations

and young adult participants with recurrent or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma...

Enrolling
Hodgkin Disease
Lymphoma, Non-Hodgkin
Drug: Relatlimab
Drug: Nivolumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Berlin, Germany and 76 other locations

a bifunctional cereblon-dependent ligand-directed degrader of B-cell lymphoma 6 (BCL6), as a single agent and in combination with anti-lymphoma...

Enrolling
Relapsed/Refractory Non-Hodgkin Lymphoma
Drug: Rituximab
Drug: Glofitamab/Obinutuzumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Berlin, Germany and 34 other locations

in participants with relapsed or refractory (R/R) aggressive B-cell Non-Hodgkin's lymphoma (DLBCL) who are using a combina...

Enrolling
B-Cell Non-Hodgkins Lymphoma
Drug: Glofitamab
Drug: Gemcitabine

Phase 2

Roche
Roche

Berlin, Germany and 49 other locations

monotherapy in adult participants with relapsed/refractory B-cell non-Hodgkin lymphoma (NHL) who have received at least tw...

Enrolling
Large B-Cell Lymphoma (LBCL)
B-cell Non-Hodgkin Lymphoma
Drug: Surovatamig

Phase 2

AstraZeneca
AstraZeneca

Berlin, Germany and 92 other locations

B-cell malignancies are a group of cancers of B lymphocytes, a type of white blood cell responsible for fighting infections. The purpose of this stud...

Enrolling
Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: ABBV-525

Phase 1

AbbVie
AbbVie

Berlin, Germany and 38 other locations

this study is to find the best dose of the drug and measure the safety and efficacy of LY4152199 in participants with previously treated B-cell lymphoma...

Begins enrollment in 2 months
Lymphoma, Follicular
B-cell Lymphoma
Drug: LY4152199 - IV

Phase 1

Lilly
Lilly

Berlin, Germany and 49 other locations

Tafasitamab (Minjuvi®), Lenalidomide (Revlimid®) and Rituximab in patients ineligible for HCT-ASCT with Primary Central Nervous System Lymphoma...

Enrolling
Non-Hodgkin Lymphoma
Drug: Methotrexate
Drug: Lenalidomide

Phase 2

University of Cologne

Berlin, Germany and 5 other locations

The goal of this Long-Term Follow-Up Trial is to assess long-term safety and efficacy of Miltenyi CAR T treatment.

Enrolling
B-cell Non Hodgkin Lymphoma
Childhood Non-Hodgkin Lymphoma
Biological: MB-CART19.1
Biological: MB-CART2019.1
Miltenyi Biotec
Miltenyi Biotec

Berlin, Berlin, Germany and 6 other locations

Non-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood ce-...

Enrolling
Hematologic Cancer
Drug: ABBV-101

Phase 1

AbbVie
AbbVie

Berlin, Germany and 50 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems